CSIG-03. PROLINE GLUTAMIC ACID AND LEUCINE RICH PROTEIN 1 (PELP1) PROMOTES GLIOBLASTOMA PROGRESSION VIA β-CATENIN PATHWAY

Glioblastomas (GBM) have dismal survival rates (1 year-34.6% and 5 year-4.75%) and affect 13,000 patients per year. Standard treatment consists of surgical resection, external beam radiation therapy, adjuvant chemotherapy with temozolomide and tumor treating fields. Nonetheless, despite a heavy inve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Sareddy, Gangadhara Reddy, Zhou, Mei, Liu, Jinyou, Viswanadhapalli, Suryavathi, Gruslova, Aleksandra, Brann, Darrell, Brenner, Andrew, Vadlamudi, Ratna
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692510/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.198
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados